Darleen Sandoval
Concepts (466)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrectomy | 37 | 2025 | 126 | 9.140 |
Why?
| | Glucagon-Like Peptide 1 | 33 | 2022 | 135 | 7.260 |
Why?
| | Bariatric Surgery | 19 | 2025 | 217 | 5.590 |
Why?
| | Obesity | 51 | 2025 | 2992 | 4.960 |
Why?
| | Glucose | 34 | 2023 | 1020 | 4.360 |
Why?
| | Weight Loss | 27 | 2024 | 787 | 4.050 |
Why?
| | Homeostasis | 27 | 2025 | 621 | 3.300 |
Why?
| | Blood Glucose | 45 | 2023 | 2186 | 3.270 |
Why?
| | Glucagon-Secreting Cells | 5 | 2023 | 24 | 2.930 |
Why?
| | Hypoglycemia | 15 | 2024 | 445 | 2.920 |
Why?
| | Gastric Bypass | 11 | 2024 | 119 | 2.810 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 19 | 2020 | 82 | 2.640 |
Why?
| | Proglucagon | 9 | 2023 | 10 | 2.560 |
Why?
| | Energy Metabolism | 22 | 2024 | 922 | 2.230 |
Why?
| | Hypothalamus | 10 | 2018 | 153 | 2.050 |
Why?
| | Insulin | 37 | 2023 | 2409 | 2.030 |
Why?
| | Eating | 22 | 2024 | 380 | 1.850 |
Why?
| | Glucagon | 10 | 2021 | 109 | 1.790 |
Why?
| | Animals | 117 | 2025 | 36940 | 1.740 |
Why?
| | Diabetes Mellitus, Type 2 | 17 | 2022 | 2531 | 1.720 |
Why?
| | Body Weight | 23 | 2021 | 985 | 1.690 |
Why?
| | Diabetes Mellitus | 7 | 2021 | 1040 | 1.550 |
Why?
| | Gastrointestinal Tract | 5 | 2025 | 195 | 1.520 |
Why?
| | Receptors, Glucagon | 10 | 2019 | 27 | 1.360 |
Why?
| | Diet, High-Fat | 16 | 2024 | 247 | 1.340 |
Why?
| | Pancreas | 6 | 2021 | 329 | 1.290 |
Why?
| | Central Nervous System | 8 | 2014 | 258 | 1.240 |
Why?
| | Brain | 10 | 2025 | 2668 | 1.240 |
Why?
| | Rats | 38 | 2022 | 5647 | 1.220 |
Why?
| | Solitary Nucleus | 4 | 2023 | 23 | 1.200 |
Why?
| | Neurons | 11 | 2023 | 1590 | 1.180 |
Why?
| | Intestinal Mucosa | 7 | 2024 | 623 | 1.140 |
Why?
| | Postprandial Period | 8 | 2024 | 107 | 1.140 |
Why?
| | Rats, Long-Evans | 18 | 2020 | 125 | 1.100 |
Why?
| | Incretins | 5 | 2017 | 22 | 1.070 |
Why?
| | Mice | 53 | 2024 | 17787 | 1.020 |
Why?
| | Hyperglycemia | 6 | 2023 | 347 | 1.020 |
Why?
| | Leptin | 6 | 2020 | 236 | 1.000 |
Why?
| | Glucose Tolerance Test | 15 | 2021 | 366 | 0.940 |
Why?
| | Gastrointestinal Hormones | 2 | 2017 | 5 | 0.920 |
Why?
| | Diet, Fat-Restricted | 3 | 2021 | 79 | 0.910 |
Why?
| | Receptors, Leptin | 4 | 2020 | 23 | 0.910 |
Why?
| | Food Preferences | 6 | 2017 | 119 | 0.890 |
Why?
| | Bile Acids and Salts | 4 | 2022 | 200 | 0.860 |
Why?
| | Mice, Knockout | 23 | 2023 | 3015 | 0.850 |
Why?
| | Insulin-Secreting Cells | 6 | 2021 | 377 | 0.840 |
Why?
| | Appetite | 1 | 2024 | 69 | 0.840 |
Why?
| | Feeding Behavior | 9 | 2024 | 654 | 0.810 |
Why?
| | Stomach | 6 | 2016 | 110 | 0.760 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2023 | 195 | 0.720 |
Why?
| | Intestines | 3 | 2017 | 357 | 0.710 |
Why?
| | Food | 4 | 2017 | 164 | 0.710 |
Why?
| | Gastric Mucosa | 4 | 2025 | 55 | 0.710 |
Why?
| | Exercise | 9 | 2006 | 2057 | 0.680 |
Why?
| | Gastric Inhibitory Polypeptide | 2 | 2019 | 14 | 0.680 |
Why?
| | Signal Transduction | 13 | 2020 | 5079 | 0.670 |
Why?
| | Pancreatic Hormones | 1 | 2020 | 3 | 0.670 |
Why?
| | Oleic Acids | 1 | 2020 | 11 | 0.660 |
Why?
| | Dipeptidyl Peptidase 4 | 2 | 2019 | 13 | 0.660 |
Why?
| | Ethanolamines | 1 | 2020 | 17 | 0.660 |
Why?
| | Epinephrine | 9 | 2007 | 139 | 0.660 |
Why?
| | Male | 68 | 2024 | 67762 | 0.640 |
Why?
| | Duodenum | 3 | 2022 | 78 | 0.620 |
Why?
| | Endocannabinoids | 1 | 2020 | 63 | 0.620 |
Why?
| | Appetite Depressants | 3 | 2018 | 18 | 0.620 |
Why?
| | Fasting | 5 | 2021 | 281 | 0.610 |
Why?
| | Sex Characteristics | 4 | 2019 | 762 | 0.610 |
Why?
| | Gene Expression Regulation | 7 | 2020 | 2607 | 0.600 |
Why?
| | Lipid Metabolism | 5 | 2017 | 518 | 0.600 |
Why?
| | Peripheral Nervous System | 1 | 2018 | 20 | 0.570 |
Why?
| | Humans | 66 | 2025 | 137585 | 0.570 |
Why?
| | Liver | 6 | 2021 | 1943 | 0.560 |
Why?
| | Basal Metabolism | 1 | 2018 | 61 | 0.560 |
Why?
| | Hormones | 6 | 2013 | 143 | 0.560 |
Why?
| | Metabolism | 1 | 2017 | 42 | 0.560 |
Why?
| | Gastric Emptying | 2 | 2016 | 38 | 0.550 |
Why?
| | Mice, Inbred C57BL | 19 | 2021 | 5757 | 0.550 |
Why?
| | Gastroplasty | 4 | 2022 | 30 | 0.530 |
Why?
| | Leadership | 1 | 2021 | 388 | 0.530 |
Why?
| | Diabetes Mellitus, Type 1 | 8 | 2019 | 3715 | 0.530 |
Why?
| | Anorexia | 2 | 2014 | 17 | 0.510 |
Why?
| | Prader-Willi Syndrome | 1 | 2016 | 31 | 0.500 |
Why?
| | N-Acetylglucosaminyltransferases | 2 | 2022 | 22 | 0.500 |
Why?
| | Jejunum | 1 | 2015 | 31 | 0.490 |
Why?
| | Peptides | 11 | 2022 | 985 | 0.490 |
Why?
| | Intestinal Absorption | 1 | 2015 | 102 | 0.480 |
Why?
| | Running | 1 | 2018 | 230 | 0.470 |
Why?
| | Glucose Clamp Technique | 12 | 2015 | 195 | 0.450 |
Why?
| | Apolipoproteins A | 1 | 2014 | 19 | 0.450 |
Why?
| | Disease Models, Animal | 14 | 2021 | 4295 | 0.440 |
Why?
| | Hyperphagia | 1 | 2014 | 34 | 0.430 |
Why?
| | Rhombencephalon | 2 | 2018 | 31 | 0.420 |
Why?
| | Venoms | 6 | 2017 | 29 | 0.410 |
Why?
| | Glucokinase | 1 | 2012 | 15 | 0.400 |
Why?
| | Ribosomal Proteins | 1 | 2013 | 93 | 0.400 |
Why?
| | Vitamin D | 1 | 2016 | 397 | 0.390 |
Why?
| | Malabsorption Syndromes | 2 | 2011 | 16 | 0.390 |
Why?
| | Ileum | 1 | 2013 | 119 | 0.390 |
Why?
| | Triglycerides | 5 | 2021 | 524 | 0.390 |
Why?
| | Adaptation, Physiological | 2 | 2015 | 553 | 0.380 |
Why?
| | Contraceptives, Oral | 2 | 2003 | 43 | 0.380 |
Why?
| | Malnutrition | 1 | 2013 | 83 | 0.370 |
Why?
| | Estradiol | 2 | 2007 | 521 | 0.370 |
Why?
| | Norepinephrine | 8 | 2007 | 204 | 0.370 |
Why?
| | Emotions | 1 | 2017 | 548 | 0.360 |
Why?
| | Lipids | 6 | 2021 | 672 | 0.360 |
Why?
| | Insulin Resistance | 5 | 2018 | 1208 | 0.350 |
Why?
| | Hypoglycemic Agents | 10 | 2019 | 1291 | 0.350 |
Why?
| | Receptor, Melanocortin, Type 4 | 4 | 2019 | 19 | 0.350 |
Why?
| | Toll-Like Receptor 5 | 1 | 2010 | 14 | 0.330 |
Why?
| | Liraglutide | 5 | 2018 | 30 | 0.330 |
Why?
| | Dietary Fats | 7 | 2014 | 304 | 0.330 |
Why?
| | Fibroblast Growth Factors | 3 | 2022 | 172 | 0.320 |
Why?
| | Dexamethasone | 3 | 2017 | 368 | 0.320 |
Why?
| | Stress, Physiological | 2 | 2003 | 443 | 0.320 |
Why?
| | Neural Pathways | 2 | 2024 | 295 | 0.320 |
Why?
| | Receptors, Somatotropin | 2 | 2021 | 9 | 0.320 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2010 | 61 | 0.320 |
Why?
| | Ventromedial Hypothalamic Nucleus | 2 | 2020 | 6 | 0.310 |
Why?
| | Neurosecretory Systems | 2 | 2013 | 32 | 0.300 |
Why?
| | Immune System | 1 | 2010 | 177 | 0.300 |
Why?
| | Nicotine | 1 | 2011 | 334 | 0.300 |
Why?
| | Autonomic Nervous System Diseases | 2 | 2006 | 36 | 0.290 |
Why?
| | Female | 28 | 2025 | 73304 | 0.290 |
Why?
| | Enteroendocrine Cells | 2 | 2020 | 6 | 0.290 |
Why?
| | Hydrocortisone | 5 | 2005 | 322 | 0.280 |
Why?
| | Prosencephalon | 1 | 2007 | 48 | 0.280 |
Why?
| | Arcuate Nucleus of Hypothalamus | 2 | 2021 | 16 | 0.270 |
Why?
| | Autonomic Nervous System | 3 | 2006 | 75 | 0.270 |
Why?
| | Receptors, Glucocorticoid | 2 | 2008 | 155 | 0.260 |
Why?
| | Body Composition | 7 | 2017 | 684 | 0.260 |
Why?
| | Metabolic Syndrome | 1 | 2010 | 354 | 0.250 |
Why?
| | Hyperinsulinism | 6 | 2013 | 121 | 0.250 |
Why?
| | Gene Expression | 4 | 2020 | 1502 | 0.250 |
Why?
| | Progesterone | 1 | 2007 | 254 | 0.250 |
Why?
| | Drug Delivery Systems | 1 | 2009 | 365 | 0.240 |
Why?
| | Diet | 3 | 2024 | 1278 | 0.240 |
Why?
| | Rats, Sprague-Dawley | 7 | 2008 | 2486 | 0.240 |
Why?
| | Serotonin | 2 | 2025 | 323 | 0.240 |
Why?
| | Adipose Tissue | 4 | 2021 | 635 | 0.230 |
Why?
| | Muscle, Skeletal | 6 | 2021 | 1724 | 0.230 |
Why?
| | Hypoxia | 2 | 2003 | 1112 | 0.230 |
Why?
| | Lactic Acid | 2 | 2003 | 305 | 0.220 |
Why?
| | Adiposity | 4 | 2019 | 518 | 0.220 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2004 | 46 | 0.210 |
Why?
| | Adipose Tissue, White | 3 | 2020 | 41 | 0.210 |
Why?
| | Anti-Obesity Agents | 1 | 2024 | 57 | 0.210 |
Why?
| | Smoking | 1 | 2011 | 1627 | 0.210 |
Why?
| | Ghrelin | 2 | 2013 | 36 | 0.200 |
Why?
| | Streptozocin | 1 | 2023 | 21 | 0.200 |
Why?
| | Ethanol | 1 | 2007 | 608 | 0.200 |
Why?
| | Altitude Sickness | 2 | 2001 | 153 | 0.200 |
Why?
| | Mice, Transgenic | 4 | 2020 | 2167 | 0.190 |
Why?
| | Estrogen Replacement Therapy | 1 | 2003 | 146 | 0.190 |
Why?
| | Endocrine Glands | 1 | 2002 | 15 | 0.190 |
Why?
| | Lactobacillus | 1 | 2022 | 29 | 0.190 |
Why?
| | Postoperative Complications | 3 | 2019 | 2654 | 0.180 |
Why?
| | Neuronal Plasticity | 1 | 2024 | 290 | 0.180 |
Why?
| | Water-Electrolyte Balance | 1 | 2001 | 34 | 0.180 |
Why?
| | Adipocytes | 3 | 2019 | 222 | 0.180 |
Why?
| | Pancreatitis | 3 | 1997 | 134 | 0.180 |
Why?
| | Gastrointestinal Microbiome | 2 | 2019 | 697 | 0.180 |
Why?
| | Glucagon-Like Peptide-2 Receptor | 2 | 2020 | 9 | 0.180 |
Why?
| | Corticosterone | 3 | 2007 | 236 | 0.180 |
Why?
| | Circadian Rhythm | 4 | 2019 | 468 | 0.180 |
Why?
| | Nucleus Accumbens | 1 | 2022 | 138 | 0.180 |
Why?
| | Energy Intake | 5 | 2018 | 485 | 0.170 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2020 | 36 | 0.170 |
Why?
| | Glutamic Acid | 1 | 2022 | 246 | 0.170 |
Why?
| | Ovariectomy | 1 | 2021 | 152 | 0.170 |
Why?
| | Body Mass Index | 2 | 2021 | 2389 | 0.170 |
Why?
| | Scavenger Receptors, Class B | 1 | 2020 | 14 | 0.170 |
Why?
| | Receptors, Calcitonin | 1 | 2020 | 3 | 0.170 |
Why?
| | Glucose Intolerance | 4 | 2014 | 146 | 0.160 |
Why?
| | PPAR alpha | 1 | 2020 | 58 | 0.160 |
Why?
| | Bromocriptine | 1 | 2019 | 30 | 0.160 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2022 | 243 | 0.160 |
Why?
| | Linagliptin | 1 | 2019 | 5 | 0.160 |
Why?
| | Dopamine Agonists | 1 | 2019 | 39 | 0.160 |
Why?
| | Mice, Obese | 2 | 2017 | 66 | 0.160 |
Why?
| | Integrases | 1 | 2020 | 120 | 0.160 |
Why?
| | Anti-Inflammatory Agents | 1 | 2003 | 496 | 0.160 |
Why?
| | Pancreas, Exocrine | 1 | 2019 | 7 | 0.160 |
Why?
| | Gene Expression Profiling | 2 | 2019 | 1774 | 0.160 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2019 | 74 | 0.150 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 47 | 0.150 |
Why?
| | Cat Diseases | 1 | 2019 | 21 | 0.150 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2019 | 14 | 0.150 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 2016 | 32 | 0.150 |
Why?
| | Gene Knockout Techniques | 1 | 2019 | 118 | 0.150 |
Why?
| | Dyslipidemias | 1 | 2020 | 176 | 0.150 |
Why?
| | Bone Resorption | 1 | 2019 | 86 | 0.150 |
Why?
| | Administration, Oral | 2 | 2020 | 816 | 0.150 |
Why?
| | Cardiovascular System | 3 | 2006 | 137 | 0.150 |
Why?
| | Dog Diseases | 1 | 2019 | 64 | 0.140 |
Why?
| | Bone Marrow Cells | 1 | 2019 | 316 | 0.140 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2020 | 220 | 0.140 |
Why?
| | Arterivirus Infections | 1 | 2017 | 1 | 0.140 |
Why?
| | Equidae | 1 | 2017 | 6 | 0.140 |
Why?
| | Nuclear Proteins | 2 | 2022 | 712 | 0.140 |
Why?
| | Stem Cells | 1 | 2022 | 594 | 0.140 |
Why?
| | Sensation | 1 | 2017 | 53 | 0.140 |
Why?
| | Sexual Maturation | 1 | 2017 | 55 | 0.130 |
Why?
| | Injections, Intraperitoneal | 1 | 2017 | 114 | 0.130 |
Why?
| | Gene Targeting | 1 | 2017 | 81 | 0.130 |
Why?
| | Up-Regulation | 1 | 2020 | 843 | 0.130 |
Why?
| | Diterpenes | 1 | 1996 | 31 | 0.130 |
Why?
| | Testis | 1 | 2017 | 151 | 0.130 |
Why?
| | Platelet Activating Factor | 1 | 1996 | 76 | 0.130 |
Why?
| | Immunohistochemistry | 3 | 2016 | 1738 | 0.130 |
Why?
| | Inflammation | 4 | 2019 | 2837 | 0.130 |
Why?
| | Dietary Carbohydrates | 2 | 2014 | 155 | 0.130 |
Why?
| | Organ Specificity | 1 | 2017 | 305 | 0.130 |
Why?
| | Physical Conditioning, Animal | 2 | 2016 | 257 | 0.130 |
Why?
| | Receptors, Calcitriol | 1 | 2016 | 55 | 0.120 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 976 | 0.120 |
Why?
| | Cholesterol | 1 | 2018 | 410 | 0.120 |
Why?
| | Electrophysiology | 1 | 2016 | 217 | 0.120 |
Why?
| | Lighting | 1 | 2015 | 26 | 0.120 |
Why?
| | Sex Factors | 1 | 2021 | 2071 | 0.120 |
Why?
| | Heterozygote | 2 | 2012 | 293 | 0.110 |
Why?
| | Microbiota | 1 | 2022 | 762 | 0.110 |
Why?
| | Sheep | 1 | 2017 | 856 | 0.110 |
Why?
| | MicroRNAs | 1 | 2021 | 692 | 0.110 |
Why?
| | Cell Differentiation | 1 | 2022 | 1991 | 0.110 |
Why?
| | Injections, Intraventricular | 2 | 2004 | 55 | 0.110 |
Why?
| | Receptors, Ghrelin | 1 | 2013 | 8 | 0.110 |
Why?
| | Adult | 13 | 2025 | 37929 | 0.100 |
Why?
| | Satiation | 1 | 2013 | 24 | 0.100 |
Why?
| | Testosterone | 1 | 2017 | 409 | 0.100 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2013 | 37 | 0.100 |
Why?
| | Dietary Proteins | 1 | 2014 | 135 | 0.100 |
Why?
| | Oxygen | 1 | 2018 | 931 | 0.100 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2012 | 12 | 0.100 |
Why?
| | Diabetes Complications | 1 | 2014 | 227 | 0.100 |
Why?
| | Sleep Deprivation | 1 | 2015 | 174 | 0.100 |
Why?
| | Glucocorticoids | 1 | 2017 | 594 | 0.100 |
Why?
| | Ribonucleotides | 1 | 2012 | 26 | 0.100 |
Why?
| | Satiety Response | 1 | 2012 | 10 | 0.100 |
Why?
| | Sympathetic Nervous System | 2 | 2004 | 182 | 0.100 |
Why?
| | Electric Stimulation | 1 | 2013 | 264 | 0.100 |
Why?
| | Pulmonary Gas Exchange | 2 | 2003 | 121 | 0.100 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 220 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 860 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 346 | 0.090 |
Why?
| | Genetic Markers | 1 | 2013 | 344 | 0.090 |
Why?
| | Weight Gain | 2 | 2016 | 519 | 0.090 |
Why?
| | Peptide YY | 1 | 2011 | 17 | 0.090 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2015 | 279 | 0.090 |
Why?
| | Exercise Therapy | 1 | 2016 | 443 | 0.090 |
Why?
| | Models, Animal | 1 | 2013 | 384 | 0.090 |
Why?
| | Reference Values | 2 | 2003 | 816 | 0.090 |
Why?
| | RNA, Messenger | 3 | 2017 | 2833 | 0.090 |
Why?
| | Islets of Langerhans | 1 | 2017 | 803 | 0.090 |
Why?
| | Apoptosis | 4 | 2013 | 2553 | 0.090 |
Why?
| | Macrophages | 2 | 2017 | 1547 | 0.090 |
Why?
| | Neutrophils | 1 | 1996 | 1238 | 0.090 |
Why?
| | Protein Kinases | 1 | 2012 | 319 | 0.090 |
Why?
| | Intestine, Small | 2 | 2022 | 156 | 0.080 |
Why?
| | Synaptic Transmission | 1 | 2011 | 289 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3284 | 0.080 |
Why?
| | Oxygen Consumption | 2 | 2003 | 696 | 0.080 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2009 | 45 | 0.080 |
Why?
| | Bone Marrow | 2 | 2021 | 286 | 0.080 |
Why?
| | Receptors, Nicotinic | 1 | 2011 | 334 | 0.070 |
Why?
| | HEK293 Cells | 3 | 2017 | 730 | 0.070 |
Why?
| | Phenotype | 1 | 2017 | 3196 | 0.070 |
Why?
| | Sympathomimetics | 2 | 2005 | 21 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2017 | 1996 | 0.070 |
Why?
| | Appetite Regulation | 1 | 2008 | 31 | 0.070 |
Why?
| | Cell Line, Tumor | 1 | 2016 | 3412 | 0.070 |
Why?
| | Receptors, Mineralocorticoid | 1 | 2008 | 10 | 0.070 |
Why?
| | Disease Susceptibility | 1 | 2010 | 347 | 0.070 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 152 | 0.070 |
Why?
| | Infusions, Parenteral | 1 | 2007 | 40 | 0.070 |
Why?
| | Glycolysis | 2 | 2021 | 321 | 0.070 |
Why?
| | Rodentia | 2 | 2019 | 57 | 0.070 |
Why?
| | Smoking Cessation | 1 | 2011 | 442 | 0.070 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2008 | 159 | 0.070 |
Why?
| | Human Growth Hormone | 2 | 2005 | 48 | 0.060 |
Why?
| | Infusions, Intraventricular | 2 | 2017 | 3 | 0.060 |
Why?
| | Enterochromaffin-like Cells | 1 | 2025 | 2 | 0.060 |
Why?
| | Gastrins | 1 | 2025 | 8 | 0.060 |
Why?
| | Parietal Cells, Gastric | 1 | 2025 | 5 | 0.060 |
Why?
| | Gastric Acid | 1 | 2025 | 14 | 0.060 |
Why?
| | Polymerase Chain Reaction | 2 | 2019 | 1062 | 0.060 |
Why?
| | Histamine | 1 | 2025 | 67 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2016 | 10811 | 0.060 |
Why?
| | Organ Size | 2 | 2017 | 477 | 0.060 |
Why?
| | Injections, Intravenous | 1 | 2004 | 206 | 0.060 |
Why?
| | Rats, Wistar | 2 | 2016 | 455 | 0.050 |
Why?
| | Consciousness | 1 | 2003 | 27 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2025 | 560 | 0.050 |
Why?
| | Gluconeogenesis | 1 | 2003 | 79 | 0.050 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2022 | 7 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2004 | 413 | 0.050 |
Why?
| | Pancreatitis-Associated Proteins | 1 | 2022 | 6 | 0.050 |
Why?
| | Heart Rate | 2 | 2005 | 822 | 0.050 |
Why?
| | Differential Threshold | 1 | 2002 | 5 | 0.050 |
Why?
| | Glutamine | 1 | 2022 | 103 | 0.050 |
Why?
| | Blood Pressure | 3 | 2005 | 1786 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 313 | 0.050 |
Why?
| | Urine | 1 | 2001 | 59 | 0.040 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2022 | 198 | 0.040 |
Why?
| | Amino Acid Transport System y+L | 1 | 2020 | 4 | 0.040 |
Why?
| | Pulmonary Ventilation | 1 | 2001 | 79 | 0.040 |
Why?
| | Absorption, Physiological | 1 | 2020 | 4 | 0.040 |
Why?
| | Epididymis | 1 | 2020 | 12 | 0.040 |
Why?
| | Protein Phosphatase 2C | 1 | 2020 | 15 | 0.040 |
Why?
| | Blood Circulation | 1 | 2020 | 41 | 0.040 |
Why?
| | Respiration | 1 | 2001 | 199 | 0.040 |
Why?
| | Respiratory System | 1 | 2002 | 157 | 0.040 |
Why?
| | Diabetic Angiopathies | 1 | 2002 | 259 | 0.040 |
Why?
| | Ceruletide | 2 | 1997 | 4 | 0.040 |
Why?
| | Kinetics | 1 | 2004 | 1670 | 0.040 |
Why?
| | CLOCK Proteins | 1 | 2019 | 8 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2003 | 1316 | 0.040 |
Why?
| | Exercise Test | 1 | 2003 | 625 | 0.040 |
Why?
| | Prolactin | 1 | 2019 | 96 | 0.040 |
Why?
| | Venezuela | 1 | 2019 | 8 | 0.040 |
Why?
| | Psychodidae | 1 | 2019 | 8 | 0.040 |
Why?
| | Animals, Domestic | 1 | 2019 | 17 | 0.040 |
Why?
| | Metabolomics | 1 | 2024 | 678 | 0.040 |
Why?
| | Zoonoses | 1 | 2019 | 33 | 0.040 |
Why?
| | Diet, Reducing | 1 | 2019 | 89 | 0.040 |
Why?
| | Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2018 | 10 | 0.040 |
Why?
| | Cats | 1 | 2019 | 210 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2008 | 1242 | 0.040 |
Why?
| | Vesicular Glutamate Transport Protein 2 | 1 | 2018 | 15 | 0.040 |
Why?
| | Chile | 1 | 2017 | 24 | 0.030 |
Why?
| | GABAergic Neurons | 1 | 2018 | 35 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.030 |
Why?
| | Adenylate Kinase | 1 | 2017 | 26 | 0.030 |
Why?
| | Colon | 1 | 2020 | 282 | 0.030 |
Why?
| | Dogs | 1 | 2019 | 413 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2019 | 294 | 0.030 |
Why?
| | Acute Disease | 2 | 2000 | 1007 | 0.030 |
Why?
| | Leukocytes | 1 | 2019 | 311 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2018 | 269 | 0.030 |
Why?
| | Cricetulus | 1 | 2017 | 109 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 353 | 0.030 |
Why?
| | CHO Cells | 1 | 2017 | 161 | 0.030 |
Why?
| | Bone Density | 1 | 2021 | 489 | 0.030 |
Why?
| | CD4-CD8 Ratio | 1 | 2017 | 22 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 660 | 0.030 |
Why?
| | Pro-Opiomelanocortin | 1 | 2016 | 18 | 0.030 |
Why?
| | Anti-Mullerian Hormone | 1 | 2017 | 57 | 0.030 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 1997 | 164 | 0.030 |
Why?
| | Ginkgolides | 1 | 1996 | 4 | 0.030 |
Why?
| | Amylases | 1 | 1996 | 17 | 0.030 |
Why?
| | Phosphorylation | 2 | 2018 | 1759 | 0.030 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 1997 | 130 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 390 | 0.030 |
Why?
| | Antigens, CD19 | 1 | 1997 | 123 | 0.030 |
Why?
| | Tyrosine | 1 | 1997 | 222 | 0.030 |
Why?
| | Lactones | 1 | 1996 | 56 | 0.030 |
Why?
| | Metformin | 1 | 2020 | 331 | 0.030 |
Why?
| | Lipase | 1 | 1996 | 69 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2020 | 561 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2018 | 437 | 0.030 |
Why?
| | Catecholamines | 1 | 2016 | 98 | 0.030 |
Why?
| | Adipokines | 1 | 2016 | 49 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2003 | 3556 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 1997 | 289 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 327 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2018 | 665 | 0.030 |
Why?
| | Pancreatic Ducts | 1 | 1996 | 85 | 0.030 |
Why?
| | Altitude | 1 | 2000 | 488 | 0.030 |
Why?
| | Nerve Net | 1 | 2018 | 256 | 0.030 |
Why?
| | Mutation | 2 | 2019 | 3958 | 0.030 |
Why?
| | Peptide Hormones | 1 | 2014 | 11 | 0.030 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 2014 | 9 | 0.030 |
Why?
| | Viral Proteins | 1 | 2017 | 342 | 0.030 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 319 | 0.030 |
Why?
| | Paracrine Communication | 1 | 2014 | 65 | 0.030 |
Why?
| | Cecum | 1 | 2014 | 33 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2017 | 412 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 596 | 0.030 |
Why?
| | Peripheral Nerves | 1 | 2014 | 65 | 0.030 |
Why?
| | Transcription Factors | 1 | 2022 | 1719 | 0.030 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2013 | 21 | 0.030 |
Why?
| | Glucose Transporter Type 4 | 1 | 2013 | 40 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2017 | 483 | 0.030 |
Why?
| | Phylogeny | 1 | 2017 | 904 | 0.030 |
Why?
| | Tamoxifen | 1 | 2014 | 202 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2057 | 0.020 |
Why?
| | Middle Aged | 2 | 2025 | 33479 | 0.020 |
Why?
| | Dopamine beta-Hydroxylase | 1 | 2012 | 14 | 0.020 |
Why?
| | Food, Formulated | 1 | 2012 | 14 | 0.020 |
Why?
| | Soybean Oil | 1 | 2012 | 14 | 0.020 |
Why?
| | Emulsions | 1 | 2012 | 53 | 0.020 |
Why?
| | Cues | 1 | 2015 | 314 | 0.020 |
Why?
| | Caloric Restriction | 1 | 2013 | 124 | 0.020 |
Why?
| | Sucrose | 1 | 2012 | 110 | 0.020 |
Why?
| | Intubation, Gastrointestinal | 1 | 2012 | 79 | 0.020 |
Why?
| | Carnitine | 1 | 2012 | 84 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2012 | 185 | 0.020 |
Why?
| | Homozygote | 1 | 2012 | 203 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 1997 | 847 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2844 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2012 | 180 | 0.020 |
Why?
| | Phospholipids | 1 | 2012 | 223 | 0.020 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 605 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2012 | 382 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2011 | 120 | 0.020 |
Why?
| | Agouti-Related Protein | 1 | 2010 | 3 | 0.020 |
Why?
| | Choice Behavior | 1 | 2012 | 170 | 0.020 |
Why?
| | Neuropeptide Y | 1 | 2010 | 14 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2012 | 377 | 0.020 |
Why?
| | Chronic Disease | 1 | 2016 | 1793 | 0.020 |
Why?
| | Taste | 1 | 2012 | 229 | 0.020 |
Why?
| | Reward | 1 | 2012 | 244 | 0.020 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2009 | 8 | 0.020 |
Why?
| | Water | 1 | 2012 | 460 | 0.020 |
Why?
| | Chemokine CCL3 | 1 | 2008 | 16 | 0.020 |
Why?
| | Behavior, Animal | 1 | 2012 | 501 | 0.020 |
Why?
| | United States | 1 | 2006 | 14841 | 0.020 |
Why?
| | Receptors, CCR2 | 1 | 2008 | 40 | 0.020 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 61 | 0.020 |
Why?
| | Mesentery | 1 | 2008 | 48 | 0.020 |
Why?
| | Fludrocortisone | 1 | 2008 | 3 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2008 | 115 | 0.020 |
Why?
| | Cell Count | 1 | 2008 | 324 | 0.020 |
Why?
| | Piperidines | 1 | 2009 | 206 | 0.020 |
Why?
| | Genotype | 1 | 2012 | 1916 | 0.020 |
Why?
| | Genetic Variation | 1 | 2012 | 991 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2008 | 372 | 0.020 |
Why?
| | Mitochondria | 1 | 2012 | 948 | 0.020 |
Why?
| | Pyrazoles | 1 | 2009 | 423 | 0.010 |
Why?
| | Antigens, CD | 1 | 2008 | 521 | 0.010 |
Why?
| | Pancreatic Polypeptide | 1 | 2005 | 3 | 0.010 |
Why?
| | Calorimetry, Indirect | 1 | 2005 | 84 | 0.010 |
Why?
| | Pregnancy | 1 | 2017 | 6763 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 431 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2005 | 786 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2005 | 706 | 0.010 |
Why?
| | Biopsy | 1 | 2005 | 1129 | 0.010 |
Why?
| | Atmospheric Pressure | 1 | 2000 | 23 | 0.010 |
Why?
| | Drinking | 1 | 2000 | 42 | 0.010 |
Why?
| | Urination | 1 | 2000 | 45 | 0.010 |
Why?
| | Adolescent | 1 | 2019 | 21513 | 0.010 |
Why?
| | Kidney Function Tests | 1 | 2000 | 160 | 0.010 |
Why?
| | Models, Biological | 1 | 2005 | 1783 | 0.010 |
Why?
| | Precipitin Tests | 1 | 1997 | 100 | 0.010 |
Why?
| | Neutralization Tests | 1 | 1997 | 75 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1997 | 52 | 0.010 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 45 | 0.010 |
Why?
| | Biological Assay | 1 | 1997 | 124 | 0.010 |
Why?
| | Cell Separation | 1 | 1997 | 318 | 0.010 |
Why?
| | Opossums | 1 | 1996 | 9 | 0.010 |
Why?
| | Ligation | 1 | 1996 | 92 | 0.010 |
Why?
| | Rabbits | 1 | 1997 | 794 | 0.010 |
Why?
| | Antibodies | 1 | 1997 | 410 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1996 | 443 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 1997 | 366 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 852 | 0.010 |
Why?
| | Necrosis | 1 | 1996 | 246 | 0.010 |
Why?
| | Cell Death | 1 | 1996 | 374 | 0.010 |
Why?
| | NF-kappa B | 1 | 1997 | 691 | 0.010 |
Why?
| | DNA Damage | 1 | 1996 | 420 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 1997 | 1142 | 0.010 |
Why?
| | Kidney | 1 | 2000 | 1468 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2000 | 2828 | 0.010 |
Why?
| | Protein Binding | 1 | 1997 | 2224 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1997 | 4193 | 0.010 |
Why?
| | DNA | 1 | 1996 | 1459 | 0.000 |
Why?
|
|
Sandoval's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|